Principles of management of patient with asymptomatic elevation of serum aminotransferases
Abstract
The aim of publication. Absence of clear practical guidelines on management of patients with asymptomatic elevation of serum aminotransferases can cause difficulties for general practitioners. Presented clinical case illustrates management approach in such cases.
The basic contents. Patient D. has admitted to the clinic in July, 2010 for changes blood biochemistry at absence of any symptoms or clinical signs. According to past history it was known: the patient is non-smoker, absolutely denies use of pharmaceuticals and alcohol abuse. At physical examination excessive body weight (BMI of 31 kg/m2) drew attention. The aim of investigation was definition of the cause of elevation of serum aminotransferases activity, and assessment of approach to further management. According to the data of carried out investigation the non-alcoholic steatohepatitis has been diagnosed, that was successfully treated by combination of metformin and ursodeoxycholic acid.
Conclusion. Estimating the submitted clinical case it is possible to conclude, that there is no strict association between accumulation of subcutaneous fat and severity of liver steatosis. Hence, non-alcoholic steatohepatitis always should be included in differential diagnostic range of search in patients with asymptomatic elevation of serum aminotransferases. For treatment of nonalcoholic steatohepatitis it is rational to use as drugs of choice metformin (treatment of insulin resistance) and ursodeoxycholic acid (anti-oxidative properties).
About the Authors
Ye. N. GermanRussian Federation
M. V. Mayevskaya
Russian Federation
Ye. O. Lyusina
Russian Federation
V. T. Ivashkin
Russian Federation
References
1. Богомолов П.О., Павлова Т.В. Неалкогольный стеатогепатит: патофизиология, патоморфология, клиника и подходы к лечению // Фарматека. – 2003. – Т. 73, № 10. – С. 12–15.
2. Буеверов А.О., Богомолов П.О. Неалкогольная жировая болезнь печени: обоснование патогенетической терапии // Клин. перспективы гастроэнтерол. – 2009. – № 1. – С. 3–9.
3. Ивашкин В.Т., Маевская М.В. Липотоксичность и метаболические нарушения при ожирении // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2010. – Т. 20, № 1. – С. 4–13.
4. AGA. Medical position statement: evaluation of liver chemistry tests // Gastroenterology. – 2002. – Vol. 123. – P. 1365.
5. Giboney P.T. Mildly elevated liver transaminase levels in the asymptomatic patient // Am. Fam. Physician. – 2005. – Vol. 71, N 6. – P. 1105–1111.
6. Katz A., Nambi S.S. Quantitive insulin sensitivity check index: a simple accurate method for assessing insulin sensitivity in humans // J. Clin. Endocrinol. Metab. – 2000. – Vol. 85, N 7. – P. 2402–2410.
7. Loria P., Carulli L. Endocrine and liver interaction: the role of endocrine pathways in NASH // Nat. Rev. Gastroenterol. Hepatol. – 2009. – Vol. 6, N 4. – P. 236–247.
8. Mendez-Sanchez N., Motola-Kuba D. Hypertransaminasemia and severe hepatic steatosis without inflammation // Ann. Hepatol. – 2003. – Vol. 2, N 4. – P. 183–185.
9. Pratt D.S., Kaplan M.M. Evaluation of abnormal liver enzyme results in asymptomatic patients // N. Engl. J. Med – 2000. – Vol. 343, N 9. – P. 662–663.
10. Ratzui V., Zelber-Sagi S. Pharmacologic therapy of non-alcoholic steatohepatitis // Clin. Liver Dis. – 2009. – Vol. 13, N 4. – P. 667–688.
Review
For citations:
German Ye.N., Mayevskaya M.V., Lyusina Ye.O., Ivashkin V.T. Principles of management of patient with asymptomatic elevation of serum aminotransferases. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2011;21(1):63-68. (In Russ.)